Adjuvant chemotherapy for elderly patients with colorectal cancer: a single-center observational study in Japan

Authors:

Abstract
Purpose: Adjuvant chemotherapy improves the prognosis of patients with colorectal cancer (CRC) following radical resection. The aim of the present study is to review appropriate chemotherapeutic regimens for elderly patients. Methods: We examined 1243 Japanese patients who received adjuvant therapy for high-risk stage II, III, or IV CRC between July 2010 and June 2021 at our hospital. Patients were divided according to an age of 70 years. The efficacy of adjuvant therapy was analyzed in association with age and adjuvant chemotherapeutic regimens. Results: A total of 544 patients (44%) were ≥70 years old. They were less likely to receive adjuvant chemotherapy (ppp=0.006); however, CSS by regimens did not significantly differ between these groups. Adjuvant chemotherapy was associated with the longer relapse-free survival of stage III CRC patients in the p=0.005). CSS in these patients was prolonged in both the p=0.019) and ≥70 years group (p=0.009) who received adjuvant chemotherapy.. Conclusions: Although adjuvant chemotherapy was associated with a favorable prognosis regardless of age, the implementation rate of adjuvant chemotherapy for elderly CRC patients was low, which may explain shorter CSS in stage III CRC patients the ≥70 years group than in the <70 years group. Further studies are needed to establish an optimal adjuvant regimen for elderly patients.

This publication has 29 references indexed in Scilit: